<DOC>
	<DOCNO>NCT02048189</DOCNO>
	<brief_summary>This open multicentre , randomize study compare two treatment arm . One arm call `` intensification multiple injection '' patient receive one supplementary injection LEVEMIR® : say 5 injection per day , arm call `` continuous insulin infusion '' via external pump APIDRA® . In pump arm : favorable effect term improve insulin sensitivity , improve metabolic equilibrium , decrease area baseline prandial hyperglycemia curve note continuous glycemia recording ; improvement quality life compare treatment use multiple injection .</brief_summary>
	<brief_title>Treatment With Continuous Sub-cutaneous Insulin Infusion Via Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Persons provide write informed consent Age &gt; 18 year Patients type 2 diabetes treat insulin use basal / bolus strategy least 6 month Doses insulin &gt; 0.7 U / Kg / HbA1c ≥ 7.5 % Without OAD least 4 week ( sulfamides , Incretines , glinides , acarbose ) except Metformin BMI ≥ 28.5 kg / m2 Diabetes diagnose least 10 year Patients able monitor manage insulin pump . Patients treat glitazones 3 month precede inclusion Patients proliferative ischemic retinopathy treat laser BMI &lt; 28.5 kg / m2 Presence implantable material ( CI MRI ) Pacemaker ( CI MRI ) Pregnancy , breast feeding Medically significant physical psychiatric inability , patient guardianship ward court The practice violent sport Poor condition hygiene Professional environment extreme cold heat .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>